[Results of 5-fluorouracil, methotrexate, cyclophosphamide and prednisone combination therapy in the treatment of advanced breast cancer].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007275:Injections, Intravenous; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate
Resultados de la combinación quimioterápica: 5-fluoruracilo, methotrexate, ciclofosfamida y prednisona en el tratamiento de cáncer de mama avanzado.